COMP <GO>
NEOG vs JNJ // GROSS PROFIT MARGIN
Neogen Corporation (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: NEOG 1
— JNJ 9
▲ GROSS PROFIT MARGIN LEADER: JNJ
LAST: $12.26 (+1.16%) • MKT CAP: $2.68B
gross-margins
46.90%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NEOG VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NEOG | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 46.90% | 67.90% | -21.00 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -0.60% | 25.50% | -26.10 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.11% | 2.97% | +0.14 | NEOG | /fcf-yield <GO> |
| Operating Margin | -2.50% | 34.70% | -37.20 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -0.90% | 28.50% | -29.40 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | -2.70% | 6.00% | -8.70 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.45 | 5.59 | -4.14 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.3 | 62.1 | -16.85 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.68B | $662.49B | -$659.82B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NEOG REV | JNJ REV | NEOG GROSS % | JNJ GROSS % | NEOG FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $870.4M | $94.19B | 46.9% | 67.9% | $83.2M | $19.70B |
| FY 2024 | $894.7M | $88.82B | 47.1% | 69.1% | $58.2M | $19.84B |
| FY 2023 | $924.2M | $85.16B | — | — | $35.3M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NEOG // BETA —
JNJ // BETA 1.08